Previous 10 | Next 10 |
PLEASANTON, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the first quarter ended March 31, 2021. Recent Highlights Revenue was $105.8 million for the first quarter, representing a 47% increase over the co...
PLEASANTON, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming BofA Securities 2021 Virtual Healthcare Conference. 10x Genomics’ management is scheduled to present on Wednesday, May 12 ...
In this episode of Industry Focus: Wildcard , Motley Fool Analyst Maria Gallagher joins host Emily Flippen to discuss the prospects for 10x Genomics (NASDAQ: TXG) , a healthcare tech company looking to reform the way researchers discover single-cell gene expression. To c...
The American Rescue Plan stimulus package includes $10 billion to be distributed to support COVID-19 testing in schools, plus another $2.5 billion to help state and local public health agencies increase testing in underserved and high-risk communities. And that's not all: Another $4 billion...
Shares of 10x Genomics Inc. (NASDAQ:TXG) traded at a new 52-week high today of $203.19. So far today approximately 271,000 shares have been exchanged, as compared to an average 30-day volume of 823,000 shares. 10x Genomics Inc is a life science technology company based in the United Stat...
PLEASANTON, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the first quarter 2021 after market close on Wednesday, May 5th, 2021. The company’s management will webcast a corresponding conference call beginnin...
The key to success for many companies is how they develop products. That's been true for 10x Genomics (NASDAQ: TXG) as it's developed platforms for genomics research. In this video recorded on March 11, 2021 , Motley Fool CEO and co-founder Tom Gardner talks with 10x Genomi...
10x Genomics (NASDAQ: TXG) markets technology that is being used to research many diseases. Its platforms are used by researchers across the world. In this video recorded on March 11, 2021 , Motley Fool CEO and co-founder Tom Gardner talks with 10x Genomics CEO and co-found...
10x Genomics (NASDAQ: TXG) has achieved tremendous success over the last few years. Its technology is used by most of the top research laboratories across the world and by many leading biopharmaceutical companies. In this video recorded on March 11, 2021 , Motley Fool CEO a...
10x Genomics ' (NASDAQ: TXG) technology has been used by researchers to investigate multiple diseases over the last few years. In this video recorded on March 11, 2021 , Motley Fool contributor Keith Speights talks with 10x Genomics CEO and co-founder Serge Saxonov about tw...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:09 ET Kyle Mikson from Canaccord Genuity issued a price target of $32.00 for TXG on 2024-07-23 05:09:00. The adjusted price target was set to $32.00. At the time of the announcement, TXG was trading at $18.11. The overall price target consensus is at $24...
10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLEASANTON, Calif. , July 12, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report fi...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 248.0% to $0.6682 on volume of 430,252,408 shares Maxeon Solar Technologies Ltd. (MAXN) fell 15.0% to $0.2108 on volume of 237,403,092 shares NVIDIA Corporation (NVDA) rose 2.7% to $134.91 on vol...